Key Insights from SCOPE Europe 2023
Posted | November 1, 2023In October, we attended the Scope Summit EU in Barcelona. From a stall with a claw machine filled to the brim with cuddly micro-organisms to our customisable conference survival kits,…
The FDA Draft Guidance for the Industry – A Welcome Development
Posted | October 16, 2023Nearly two years on from the COVID-19 Pandemic, and in that time, the clinical trials landscape has experienced some seismic shifts. In 2020 alone, active decentralised trials increased by more…
Insights from Mobile Tech in Clinical Trials 2023
Posted | September 27, 2023The theme at the 10th annual Mobile Health in Clinical Trials event this month was ‘Supporting More Patients to Participate in Clinical Trials Remotely: What’s Working, What’s Not.’ As one…
Our insights from SCOPE 2023
Posted | February 15, 2023We had an incredible time attending SCOPE Summit 2023 in sunny Orlando, Florida. Thanks to a great turnout, we met many inspirational guests. We enjoyed in-depth conversations about the latest…
mdgroup have been shortlisted as Sunday Times 100 fastest-growing private companies
Posted | June 17, 2022We’re delighted to have been shortlisted as one of the UK's fastest-growing private companies in the inaugural Sunday Times 100 ranking. This is the first time these rankings have included…
Watch this space as Horreum redefines the supply chain for a global audience
Posted | May 20, 2022Horreum, our medical distribution centres based in the US, UK and Europe, will soon be launched as a standalone service to offer more support to clients and patients across the…
Introducing the mdtalk podcast: bringing you the best in clinical research discussions straight to your device
Posted | March 17, 2022We are delighted to announce the launch of the mdtalk podcast. Join host LaQuinta Jernigan, Executive Vice President for North America at mdgroup, as she shines a light on the…
mdgroup to partner with ERGOMED on new Rare Disease Innovation Center
Posted | March 8, 2022Collaboration will provide sponsors with access to industry-leading technology and expertise to optimise rare disease drug development and tackle unmet medical need Bracknell, UK: 28 February 2022 – mdgroup, the…
Buzzacott Organic Growth 25: mdgroup Recognised for Unprecedented Growth
Posted | February 17, 2022We’re delighted to announce our place on the Buzzacott Organic Growth 25 list, which celebrates twenty-five of the fastest growing businesses in the UK. Over the past two years, we’ve…
